Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11023089 | Life Sciences | 2018 | 24 Pages |
Abstract
Our data suggest that ATO is a potential therapeutic drug for HNSCCs, especially HPV-positive HNSCCs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shanmei Du, Kui Liu, Peng Gao, Zhongyou Li, Jie Zheng,